顺铂、重组干扰素α-2B、阿霉素和5-氟尿嘧啶经全身及肝动脉给药治疗肝细胞癌的持久临床及病理反应：一则通讯
Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication.
作者信息
Patt Y Z, Hoque A, Roh M, Ellis L, Lozano R, Carrasco C H, Charnsangavej C, Cleary K
机构信息
Department of Gastrointestinal Medical Oncology and Digestive Diseases, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
出版信息
Am J Clin Oncol. 1999 Apr;22(2):209-13. doi: 10.1097/00000421-199904000-00024.
Abstract
The case described here illustrates the antitumor activity of a four-drug systemic combination chemobiotherapy with platinol, recombinant interferon alpha 2b, doxorubicin (Adriamycin), and 5-fluorouracil (5-FU) (PIAF) in a patient with diffuse hepatocellular carcinoma involving the liver and lungs.
摘要
本文所述病例展示了铂尔定、重组干扰素α2b、阿霉素及5-氟尿嘧啶（PIAF）四药联合全身化学生物疗法对一名肝脏和肺部均有弥漫性肝细胞癌患者的抗肿瘤活性。
Zotero 插件